Abstracts from the 2004 Conference, London

View these abstracts sorted by title

1. PREDICTING PRESCRIBING TRENDS IN GENERAL PRACTICE
   Åström K, Duggan C, Bates I
2. EVALUATING PHARMACEUTICAL CONSULTATIONS: THE DEVELOPMENT OF A "MEDICATION-RELATED CONSULTATION FRAMEWORK"
   Abdel Tawab R, James D, Davies JG, & Horne R
3. REMOTE SUPERVISION: THE VIEWS OF PHARMACY CUSTOMERS
   Bissell P & Anderson C.
4. HEALTH CARE OUTCOME INDICATORS ARE RELATED TO HOSPITAL PHARMACY WORKFORCE
   Borja-Lopetegi A, Bates I, Webb DG, Sharott P
5. WHAT IS DRIVING LOCAL DEVELOPMENT OF COMMUNITY PHARMACY?
   Celino GJ, Gray NJ, Blenkinsopp A, Dhalla M
6. STATINS AND THE INTERFACE BETWEEN PATIENT AND COMMUNITY PHARMACIST
   Chatterton M, Blenkinsopp A, Pollock K.
7. SYSTEMATIC REVIEW OF THE ANALGESIC EFFICACY AND TOLERABILITY OF COX-2 INHIBITORS IN POSTOPERATIVE PAIN CONTROL
   Chen L, Elliott R, Ashcroft D
8. DO TOMORROW'S DOCTORS AND PHARMACISTS WANT SHARED LEARNING? ANALYSIS OF A PILOT INTERDISCIPLINARY PROJECT
   Diack HL, Bond CM, Edwards R, Healey TM, Mackenzie H
9. SOCIAL CAPITAL AND PHARMACY: AN EXPLORATORY STUDY
   Fenner L, Bissell P, Anderson C.
10. CAN HUMAN ERROR THEORY PREDICT NON-COMPLIANCE? A TEST OF THE MODEL
    Furlong J, Knapp P, Lawton R.
11. DOSING ERRORS IN PAEDIATRIC MEDICATIONS – A SYSTEMATIC REVIEW
    Ghaleb MA, Wong ICK, Franklin BD, Barber N
12. THE MEDICINES INFORMATION NEEDS OF OLDER PEOPLE WITH SIGHT LOSS: PRELIMINARY FINDINGS
    Gibson M, Knapp P, Turpin P, Raynor DK, Atkin K
13. DRUG-RELATED PROBLEMS: WHAT DO PATIENTS AND HEALTH CARE PROFESSIONALS CONSIDER IMPORTANT?
    Gordon KJ , Dhillon S and Smith FJ
14. 'ASK ABOUT MEDICINES': AN ONLINE QUIZ FOR ADOLESCENTS
    Gray NJa, McPherson Ab, MacFarlane Ac
15. A METHOD FOR INTERNATIONAL TRANSLATION OF PREVENTABLE DRUG-RELATED MORBIDITY INDICATORS IN COMMUNITY PHARMACY
    Guerreiro M, Cantrill J, Martins P
16. BARRIERS TO COMMUNITY NURSE PRESCRIBING
    Hall J, Cantrill J, Noyce P
17. THE DEVELOPMENT OF THE SOUTHERN DERBYSHIRE MEDICINES SUPPORT SERVICE
    Harris DJ
18. DIVERGENT PERSPECTIVES ON WHO IS RESPONSIBLE FOR PREVENTING DRUG RELATED MORBIDITY
    Howard R, Bissell P, Avery A.
19. THE USE OF PERMITTED AND BANNED MEDICINES IN RUGBY UNION BY MEN – A QUESTIONNAIRE STUDY
    John DN, Phillips H
20. INNOVATION IN COMMUNITY PHARMACY CONTRACTS: DESCRIBING FIRST WAVE LOCAL PHARMACEUTICAL SERVICES (LPS) PILOTS.
    Kendall J, Sibbald B, Ashcroft D, Hassell K & Noyce P.
21. CREATING RESEARCH CAPACITY IN COMMUNITY PHARMACY; DILEMMAS IN PRACTICE
    Kirkbride R, Anderson C, Gray N, Thornley T.
22. UNDERSTANDING ADHERENCE TO ANTIBIOTICS: A PROSPECTIVE STUDY
    Knapp P., Jackson, C., Raynor, D.K., Lawton, R. & Lowe, C.
23. WHAT DO PEOPLE THINK IS THE LIKELIHOOD OF HARM AND BENEFIT FROM TWO COMMON MEDICINES?
    Peter Knapp, Zubeena Coppack and DK Theo Raynor
24. EXPLORING PSYCHOSOCIAL INFLUENCES ON ADHERENCE TO ANTI-HYPERTENSIVE MEDICATION
    Maguire, L, Hughes, C & McElnay, J.
25. HOW CAN COMMUNITY PHARMACISTS ASSESS COMPETENCE?
    Mills ER, Bates I, Davies JG
26. DIFFERING DEFINITIONS OF APPROPRIATENESS
    Morecroft C, Cantrill J, Tully MP
27. INDICATORS FOR PREVENTABLE DRUG-RELATED MORBIDITY: FACILITATING CHANGES IN PRACTICE?
    Morris CJ, Cantrill JA, Avery AJ, Howard RL
28. SKILL MIX IN COMMUNITY PHARMACY: A CASE STUDY APPROACH TO EXPLORE THE ACTIVITIES OF DISPENSARY SUPPORT STAFF
    Mullen R. Hassell and Noyce PR
29. MOVEMENT OF GB TRAINED PHARMACISTS OVERSEAS
    Liza Nichols, Karen Hassell, Peter Noyce
30. WHAT IS THE EVIDENCE FOR THE USE OF MULT-COMPARTMENT COMPLIANCE AIDS BY OLDER PEOPLE LIVING IN THE COMMUNITY?
    Nunney J, Raynor DK, Knapp PR.
31. A MULTI-FACULTY STUDY OF ACADEMIC DISHONESTY
    Obiols L., Bates IP, Lacey MF, Austin Z., Davies JG
32. HOMALS METHOD GUIDING ANALYSIS OF PATIENT CHOICE IN TB PREVENTION
    Rennie TW, Bates IP, Engova D, Bothamley GH
33. RELATIONSHIP BETWEEN THE RATE OF PARACETAMOL OVERDOSE AND DEPRIVATION
    Robinson D, Johnston D, McElnay J.
34. LESSONS FROM ABROAD: THE ROLES AND RESPONSIBILITIES OF PHARMACY ASSISTANTS
    Samuels T, Mullen R, Hassell K, Noyce P.
35. "THE CHANCE TO DEVELOP MYSELF": THE ASPIRATIONS OF ESSEX PHARMACY TECHNICIANS
    Savage I, Duell P, Stanley J, Nice S, Allan J, Smith P
36. RESEARCH CAPACITY BUILDING: VIEWS OF COMMUNITY PHARMACISTS PARTICIPATING IN A COMMUNITY PHARMACIES NETWORK
    Schafheutle EI, Hassell K, Noyce PR
37. PATIENTS' EXPERIENCES OF EDUCATING PHARMACY UNDERGRADUATES
    Shah, R., Kapadia, S., Savage, I.
38. FLEXIBILITY & THE LOCUM PHARMACIST
    Shann P, Hassell K, Samuels T.
39. SELF-MANAGEMENT, WELL-BEING AND LEARNING
    Silcock J, Raynor DK, Atkin K.
40. EXPLORING THE EFFECT OF THE ELECTRONIC PATIENT RECORD ON HOSPITAL PHARMACIES: DEVELOPING A CASE STUDY APPROACH
    Smith GM, Cantrill J, Tully MP.
41. IDENTIFYING OPPORTUNITIES FOR PHARMACY INVOLVEMENT IN ASTHMA SERVICES: RESULTS FROM AN OMNIBUS SURVEY
    Thornley T, Anderson C, Gray N, Kirkbride R.
42. HUMAN ERROR THEORY (HET): A NOVEL APPROACH TO DEVELOPING STRATEGIES TO IMPROVE THE EVIDENCE BASED(EB) SUPPLY OF NON-PRESCRIPTION MEDICINES(NPMS)
    Watson MC, Bond CM, Johnston M, Mearns K.
43. A QUALITATIVE STUDY OF CARDIAC REHABILITATION PATIENTS' PERSPECTIVES ON COMPLIANCE AND CONCORDANCE WITH MEDICINES
    White S, Anderson C, Bissell P.
44. RESEARCH EVIDENCE AND ITS INFLUENCE ON POLICY: PROGRESS IN DELIVERING IMPROVED SERVICES TO DRUG USERS
    Keith Wilson, Jill Jesson and Christabel Tattersall
45. AN EXPLORATION OF THE INFLUENCE OF COMPANY POLICY ON ETHICAL DECISION MAKING BY COMMUNITY PHARMACISTS
    Wingfield J, Theophilou T, Bissell P.